Stock of the Day
April 4, 2024
Revelation Biosciences (REVB)
$0.85
+$0.03 (+3.8%)
Market Cap:
$0.80M
About Revelation Biosciences
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.
The company was founded in 2020 and is based in San Diego, California.
← Previous Stock of the Day
Next Stock of the Day →
Recent News
Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering
(finance.yahoo.com)
Revelation Biosciences sets terms for $4 million public offering
(investing.com)